HCA Healthcare (NYSE:HCA) Price Target Cut to $376.00 by Analysts at Royal Bank of Canada

HCA Healthcare (NYSE:HCA) had its target price reduced by Royal Bank of Canada from $384.00 to $376.00 in a research note released on Monday,Benzinga reports. Royal Bank of Canada currently has an outperform rating on the stock.

HCA has been the subject of a number of other research reports. Cantor Fitzgerald restated an “overweight” rating and set a $405.00 price objective on shares of HCA Healthcare in a report on Monday, January 27th. Guggenheim assumed coverage on shares of HCA Healthcare in a research report on Wednesday, April 9th. They set a “neutral” rating for the company. Baird R W downgraded shares of HCA Healthcare from a “strong-buy” rating to a “hold” rating in a report on Tuesday, April 15th. Barclays decreased their price objective on HCA Healthcare from $392.00 to $366.00 and set an “overweight” rating for the company in a report on Monday, January 27th. Finally, Truist Financial decreased their price objective on HCA Healthcare from $430.00 to $390.00 and set a “buy” rating for the company in a report on Monday, January 6th. One equities research analyst has rated the stock with a sell rating, six have assigned a hold rating, twelve have assigned a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $381.13.

HCA Healthcare Stock Up 1.3 %

Shares of NYSE:HCA opened at $332.19 on Monday. The stock has a market cap of $81.79 billion, a price-to-earnings ratio of 15.12, a P/E/G ratio of 1.10 and a beta of 1.48. The company has a 50 day moving average of $330.05 and a 200-day moving average of $331.32. The company has a debt-to-equity ratio of 69.07, a current ratio of 1.08 and a quick ratio of 0.97. HCA Healthcare has a one year low of $289.98 and a one year high of $417.14.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings data on Friday, April 25th. The company reported $6.45 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $5.75 by $0.70. The firm had revenue of $18.32 billion during the quarter, compared to analysts’ expectations of $18.26 billion. HCA Healthcare had a net margin of 8.16% and a return on equity of 586.47%. The business’s revenue for the quarter was up 5.7% on a year-over-year basis. During the same quarter in the previous year, the company earned $5.36 earnings per share. On average, sell-side analysts forecast that HCA Healthcare will post 24.98 earnings per share for the current year.

HCA Healthcare Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Monday, June 30th. Stockholders of record on Monday, June 16th will be issued a dividend of $0.72 per share. The ex-dividend date of this dividend is Monday, June 16th. This represents a $2.88 annualized dividend and a dividend yield of 0.87%. HCA Healthcare’s dividend payout ratio is 12.81%.

Insider Activity

In related news, SVP Jennifer Berres sold 9,533 shares of the company’s stock in a transaction on Friday, February 14th. The stock was sold at an average price of $322.59, for a total transaction of $3,075,250.47. Following the completion of the sale, the senior vice president now owns 15,412 shares in the company, valued at approximately $4,971,757.08. This represents a 38.22 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Corporate insiders own 1.30% of the company’s stock.

Institutional Inflows and Outflows

A number of institutional investors have recently bought and sold shares of the business. Sanders Capital LLC grew its stake in HCA Healthcare by 1.0% in the 4th quarter. Sanders Capital LLC now owns 11,655,563 shares of the company’s stock valued at $3,498,417,000 after purchasing an additional 116,826 shares during the period. First Eagle Investment Management LLC lifted its holdings in HCA Healthcare by 0.5% during the 4th quarter. First Eagle Investment Management LLC now owns 4,503,849 shares of the company’s stock worth $1,351,830,000 after purchasing an additional 23,177 shares in the last quarter. Geode Capital Management LLC grew its stake in HCA Healthcare by 1.3% in the 4th quarter. Geode Capital Management LLC now owns 3,871,057 shares of the company’s stock worth $1,159,882,000 after buying an additional 50,321 shares in the last quarter. Capital World Investors grew its stake in HCA Healthcare by 0.7% in the 4th quarter. Capital World Investors now owns 2,928,452 shares of the company’s stock worth $878,975,000 after buying an additional 19,121 shares in the last quarter. Finally, Norges Bank purchased a new position in HCA Healthcare in the 4th quarter worth approximately $840,286,000. Institutional investors own 62.73% of the company’s stock.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.